美国务卿说泽连斯基撒谎
Medipost Reports Positive Phase 3 Results for CARTISTEM in Japan’s Knee Osteoarthritis Trial_城市资讯网

Cartistem in Japan, held on Wednesday at the Four Seasons Hotel in Jongno-gu, Seoul 2026.5.13 / News1(서울=뉴스1) 문대현 기자 = Medipost announced on Wednesday that its umbilical cord-derived allogeneic mesen
3 clinical trial for knee osteoarthritis treatment in Japan. Lee Seung-jin, Head of Global Business and Chief Executive Officer (CEO) of the Japanese subsidiary, reported that they've achieved clear
当前文章:http://jxt1me.23011111.com/ocsqlj/f39t2.pptx
发布时间:02:30:30
